METABASE 30M SERIES INSIGHT PDF 125000000217 alkyl group Chemical group 0.000 claims description 101. 229910003667 SRa Inorganic materials 0.000 claims description 101. 125000001072 heteroaryl group Chemical group 0.000 claims description 102.  125000003118 aryl group Chemical group 0.000 claims description 103. 229910052739 hydrogen Inorganic materials 0.000 claims description 123. 150000001875 compounds Chemical class 0.000 claims description 139. 229910003827 NRaRb Inorganic materials 0.000 claims description 204. 229910004664 ORa Inorganic materials 0.000 claims description 309. 229910004755 ORb Inorganic materials 0.000 claims description 356. 229910003813 NRa Inorganic materials 0.000 claims description 560. 201000004681 psoriasis Diseases 0.000 claims abstract description 3. 206010023230 Joint stiffness Diseases 0.000 claims abstract description 3. 210000000987 Immune System Anatomy 0.000 claims abstract description 3.  235000020824 obesity Nutrition 0.000 claims abstract description 5.  208000008589 Obesity Diseases 0.000 claims abstract description 5.206010012601 Diabetes mellitus Diseases 0.000 claims abstract description 6.239000005483 tyrosine kinase inhibitor Substances 0.000 claims abstract description 10.201000011510 cancer Diseases 0.000 claims abstract description 13.108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 claims abstract description 13.102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 claims abstract description 13.239000003934 phosphoprotein phosphatase inhibitor Substances 0.000 claims abstract description 21.239000003909 protein kinase inhibitor Substances 0.000 claims abstract description 33.108090000623 proteins and genes Proteins 0.000 claims abstract description 45.102000004169 proteins and genes Human genes 0.000 claims abstract description 45.230000000694 effects Effects 0.000 claims abstract description 97.108060006633 Protein Kinases Proteins 0.000 title claims abstract description 100.102000001253 Protein Kinases Human genes 0.000 title claims abstract description 108.239000003112 inhibitor Substances 0.000 title claims abstract description 328.230000002401 inhibitory effect Effects 0.000 title claims abstract description 421.Publication of US20060030544A1 publication Critical patent/US20060030544A1/en Application granted granted Critical Publication of US7772216B2 publication Critical patent/US7772216B2/en Status Active legal-status Critical Current Adjusted expiration legal-status Critical Links  Assignors: MILKIEWICZ, KAREN, EL-ARABY, MOUSTAFA, HANGAUER, JR., DAVID G. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) Filing date Publication date Priority to US33619101P priority Critical Priority to US10/277,217 priority patent/US7005445B2/en Application filed by Research Foundation of State University of New York filed Critical Research Foundation of State University of New York Priority to US11/206,115 priority patent/US7772216B2/en Assigned to RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK, THE reassignment RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK, THE ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Original Assignee Research Foundation of State University of New York Priority date (The priority date is an assumption and is not a legal conclusion. Research Foundation of State University of New York Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.) ( en Inventor David Hangauer Moustafa El-Araby Karen Milkiewicz Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.) Granted Application number US11/206,115 Other versions US7772216B2 METABASE 30M SERIES INSIGHT PDF Google Patents Protein kinase and phosphatase inhibitors and methods for designing themĭownload PDF Info Publication number US20060030544A1 US20060030544A1 US11/206,115 US20611505A US2006030544A1 US 20060030544 A1 US20060030544 A1 US 20060030544A1 US 20611505 A US20611505 A US 20611505A US 2006030544 A1 US2006030544 A1 US 2006030544A1 Authority US United States Prior art keywords group aryl biaryl heteroaryl cyclic Prior art date Legal status (The legal status is an assumption and is not a legal conclusion. Google Patents US20060030544A1 - Protein kinase and phosphatase inhibitors and methods for designing them US20060030544A1 - Protein kinase and phosphatase inhibitors and methods for designing them

Metabase 30m series insight

MACOS SERVER AWS MAC OS MACOS SERVER AWS UPDATE MACOS SERVER AWS MAC AWS is working to add support for Big Sur, and for Apple M1 Chip. Mojave and Catalina AMIs comes with the AWS CLI, Command Line Tools for Xcode, Homebrew, and SSM Agent already installed. MACOS SERVER AWS MAC AWS EC2 Mac Instances come with a limitation in that sense: only Mojave or Catalina macOS versions can be selected. So far it didn't bring me tangible enhancements, but it's quite a best-practice to keep your system up to date, at least on your workstation. MACOS SERVER AWS UPDATE In my daily routine, my working partner is a macOS laptop that I had to update to the new macOS Big Sur operating system. As explained by Jeff Barr in the AWS News Blog, instances run in a VPC, include ENA networking, and are natively Optimized for communication with EBS volumes, supporting I/O intensive workloads. tal instances' hardware specifications tell us that they're powered by an Intel Coffee Lake processor running at 3.2 GHz - that can burst up to 4.6 GHz - and 32 GiB of memory. Well, as far as now, you can forget the word 'choice': AWS allows you to run only one size of Mac Instances. Peter Desantis, Senior Vice President of AWS Infrastructure and Support, presenting new Amazon EC2 Mac Instances at AWS re:Invent 2020 Infrastructure Keynote.Īt this point - assuming that you never heard about Amazon EC2 Mac Instances hardware specifications - you may wonder what are the supported sizes. I used the term 'host' to highlight the fact that we're not dealing with Virtual Machines, but with Dedicated Hosts whenever I decide to run an Amazon EC2 Mac Instance, AWS provisions a concrete Mac mini host for my purposes. The interesting point is that Mac Instances are connected to the Nitro System through the Thunderbolt 3 interface. Talking about hardware, Amazon EC2 Mac Instances are backed by Mac mini hosts, that rely on AWS Nitro controllers to connect with AWS network infrastructure and services. What I want is the equivalent behaviour and rw permissions of rw,fsid=root,all_squash,anonuid=1000,anongid=1000,no_subtree_check in my exporting, I've got it working with NFS Manager where I can mount the folder on my VM guest but read-only.During the last AWS re:Invent, AWS made one of the most discussed announcement, that - on paper - opens a lot of new scenarios: AWS EC2 Mac Instances!ĭon't worry, we will deepen one of these scenarios later on in this blog post, but let's first introduce this new instance type.Īmazon EC2 Mac Instances come with an 80s name, which makes them more attractive to those of you who are a little bit older than me 🙂. Is it just because the line in /etc/exports is crap, or I need some other configuration? or do I need the macOS Server app?įrom looking at it seems like it might not be anything I need the macOS Server app for?  Note: /path/to/my/shared/directory is obviously a just a placeholder filepath for this question, not my actual entry in /etc/exports 🤣 path/to/my/shared/directory 192.168.56.0/24(rw,fsid=root,all_squash,anonuid=1000,anongid=1000,no_subtree_check)Ĭalling nfsd checkexports returns the following: getaddrinfo() failed for 192.168.56.0/24(rw,fsid=root,all_squash,anonuid=1000,anongid=1000,no_subtree_check)Įxports:2: couldn't get address for host: 192.168.56.0/24(rw,fsid=root,all_squash,anonuid=1000,anongid=1000,no_subtree_check)Įxports:2: no valid hosts found for exportĪnd if I simplify and change the etc/exports entry to /path/to/my/shared/directory -network 192.168.56.0 -mask 255.255.255.0 I get the following output from nfsd checkexports: exports:2: path contains non-directory or non-existent components: /path/to/my/shared/directoryĮxports:2: no usable directories in export entry and no fallback My regular line in /etc/exports on Linux: # NFS Share to Virtualbox guests: This is something I am used to doing in Linux without any difficulty, but the syntax for /etc/exports doesn't seem to be the same? In the man page for exports on macOS it uses explicit flags? MACOS SERVER AWS MAC OS First of all, I'm happy to pay the $19.99 for the Mac OS Server app from the app store, so that's no problem, it's just that at the moment I only have one specific need - NFS sharing between my macOS sierra host and a virtualbox VM guest running Debian Sarge (don't ask).

Dune 2000 game app